Those strategies are generally termed “SMN-dependent.” Since motoneurons are preferentially affected independent of the clinical subtype, they are a common target for a SMN-restoration in the central nervous system and this strategy is important for all SMA cases irrespective of the severity (Table 1). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.